Trial Profile
Study assessing the immune response to the booster dose of Hepatitis B vaccine in HIV positive children with inadequate response to HBV vaccination
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Mar 2017
Price :
$35
*
At a glance
- Drugs Hepatitis B vaccine recombinant (HBvaxPro) (Primary)
- Indications Hepatitis B
- Focus Pharmacodynamics
- 24 Mar 2017 New trial record
- 16 Feb 2017 Results presented at the 24th Conference on Retroviruses and Opportunistic Infections